Adhesion

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pharmasyntez
PharmasyntezRussia - Irkutsk
2 programs
1
1
SeroguardPhase 21 trial
SeroguardPhase 11 trial
Active Trials
NCT03640559CompletedEst. Oct 2015
NCT03660787CompletedEst. Jan 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PharmasyntezSeroguard
PharmasyntezSeroguard

Clinical Trials (2)

Efficacy and Dose Ranging Study of Seroguard

Start: May 2017Est. completion: Jan 2018
Phase 2Completed

Safety and Tolerability of Seroguard Use

Start: May 2015Est. completion: Oct 2015
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space